Skip to main content
. 2018 Sep 14;112(6):294–305. doi: 10.1080/20477724.2018.1514136

Figure 2.

Figure 2.

CYD-TDV (Dengvaxia®) vaccine.

The tetravalent dengue vaccine CYD-TDV has been constructed by substituting prM and E genes from DENV-1 to DENV-4 into the backbone of the molecular clone of yellow fever vaccine YF-17D. there are four chimeric CYD-1 to CYD-4 which compose the CYD-TDV.